{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "LRRK2 mutations cause autosomal dominant PD (PARK8). I2020T is a kinase domain mutation. Neurodegeneration is associated with higher susceptibility of I2020T to degradation compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that LRRK2 mutations cause PD and links I2020T's neurodegeneration mechanism to its increased degradation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Apoptosis protection against hydrogen peroxide was tested. Proteolysis inhibitors and WT LRRK2 knockdown were used to modulate protein levels.",
          "judgment": "Yes",
          "reasoning": "Apoptosis assays are relevant to PD pathology (neuronal survival). Modulating protein levels via inhibitors/knockdown aligns with studying LRRK2's protective function.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Wild-type LRRK2 and I2020T mutant were compared. Proteolysis inhibitors and knockdown experiments were performed to test protein level effects.",
          "judgment": "No",
          "reasoning": "While wild-type and mutant comparisons were made, the text does not explicitly state multiple replicates or independent experiments.",
          "next_step_or_outcome": "Proceed to Sub-step 3b"
        },
        {
          "step_name": "Sub-step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "Apoptosis assays are standard in PD research (e.g., hydrogen peroxide-induced cell death models). Proteolysis modulation via inhibitors is a validated approach to study protein stability.",
          "judgment": "Yes",
          "reasoning": "Apoptosis assays and proteolysis inhibition are broadly accepted techniques in neurodegeneration studies.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "No statistical tests (e.g., p-values) or OddsPath calculations are explicitly reported.",
          "judgment": "No",
          "reasoning": "The paper does not provide statistical analyses or quantitative pathogenicity metrics for the variant.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Wild-type LRRK2 and I2020T mutant were used as controls. Total benign/pathogenic controls = 2 (wild-type and knocked-down WT).",
          "judgment": "Yes",
          "reasoning": "Only 2 control conditions (wild-type and knocked-down WT) are explicitly reported, totaling fewer than 11 controls.",
          "next_step_or_outcome": "Final evidence strength"
        }
      ],
      "functional_evidence_strength": "PS3_supporting",
      "overall_conclusion": "The I2020T mutation in LRRK2 exhibits higher degradation compared to wild-type, impairing its protective function against apoptosis. This supports pathogenicity (PS3_supporting), as the functional assay aligns with PD mechanisms and uses validated methods despite limited statistical rigor."
    }
  ]
}